JP2017221711A5 - - Google Patents

Download PDF

Info

Publication number
JP2017221711A5
JP2017221711A5 JP2017157752A JP2017157752A JP2017221711A5 JP 2017221711 A5 JP2017221711 A5 JP 2017221711A5 JP 2017157752 A JP2017157752 A JP 2017157752A JP 2017157752 A JP2017157752 A JP 2017157752A JP 2017221711 A5 JP2017221711 A5 JP 2017221711A5
Authority
JP
Japan
Prior art keywords
drug
electronic pill
patient
administration
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017157752A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017221711A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017221711A publication Critical patent/JP2017221711A/ja
Publication of JP2017221711A5 publication Critical patent/JP2017221711A5/ja
Pending legal-status Critical Current

Links

JP2017157752A 2008-02-18 2017-08-18 患者に対する薬物の投与 Pending JP2017221711A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2944708P 2008-02-18 2008-02-18
US61/029,447 2008-02-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010546431A Division JP6230772B2 (ja) 2008-02-18 2009-02-11 患者に対する薬物の投与

Publications (2)

Publication Number Publication Date
JP2017221711A JP2017221711A (ja) 2017-12-21
JP2017221711A5 true JP2017221711A5 (enExample) 2018-05-31

Family

ID=40521921

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010546431A Active JP6230772B2 (ja) 2008-02-18 2009-02-11 患者に対する薬物の投与
JP2017157752A Pending JP2017221711A (ja) 2008-02-18 2017-08-18 患者に対する薬物の投与

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010546431A Active JP6230772B2 (ja) 2008-02-18 2009-02-11 患者に対する薬物の投与

Country Status (5)

Country Link
US (1) US20100331827A1 (enExample)
EP (1) EP2254464B1 (enExample)
JP (2) JP6230772B2 (enExample)
CN (1) CN101945613B (enExample)
WO (1) WO2009104110A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2624907B1 (en) * 2010-10-06 2014-11-12 Medimetrics Personalized Drug Delivery B.V. Electronic pill for delivery of powder medication
US9687638B2 (en) 2011-03-24 2017-06-27 Medimetrics Personalized Drug Delivery Swallowable medication capsule
CN102567628A (zh) * 2011-12-16 2012-07-11 广东省人民医院 一种药物代谢动力学采样和数据收集系统及方法
US10264972B2 (en) 2012-05-21 2019-04-23 International Business Machines Corporation Dispensing drugs from a companion diagnostic linked smart pill
US10045713B2 (en) 2012-08-16 2018-08-14 Rock West Medical Devices, Llc System and methods for triggering a radiofrequency transceiver in the human body
US9131842B2 (en) 2012-08-16 2015-09-15 Rock West Solutions, Inc. System and methods for locating relative positions of multiple patient antennas
US9215997B2 (en) * 2012-11-16 2015-12-22 L. Zane Shuck In vivo technology system for human gut research, diagnostics and treatment
US9955922B2 (en) * 2012-11-16 2018-05-01 Lowell Zane Shuck Capsule device and methodology for discovery of gut microbe roles in diseases with origin in gut
AU2014340223B2 (en) 2013-10-22 2019-04-04 Rock West Medical Devices, Llc System to localize swallowable pill sensor with three transmitting elements
CA2964900C (en) * 2014-09-25 2023-02-21 Progenity, Inc. Electromechanical pill device with localization capabilities
CN109862821A (zh) 2016-09-09 2019-06-07 普罗根尼蒂公司 用于递送可配发物质的机电可摄入装置
CN110072519A (zh) 2016-12-14 2019-07-30 普罗根尼蒂公司 使用jak抑制剂治疗胃肠道疾病及装置
KR20190095931A (ko) 2016-12-14 2019-08-16 프로제너티, 인크. 섭취가능한 디바이스를 사용하여 방출된 il-12/il-23 저해제로의 위장관 질환의 치료
WO2018112255A1 (en) 2016-12-14 2018-06-21 Progenity Inc. Treatment of a disease of the gastrointestinal tract with an immunosuppressant
CA3046019A1 (en) 2016-12-14 2018-06-21 Progenity Inc. Treatment of a disease of the gastrointestinal tract with a tlr modulator
CA3054156A1 (en) 2017-03-30 2018-10-04 Progenity Inc. Treatment of a disease of the gastrointestinal tract with il-10 or an il-10 agonist
JP7045397B2 (ja) 2017-05-17 2022-03-31 マサチューセッツ インスティテュート オブ テクノロジー 自己復元システムおよび関連構成要素
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
AU2019269636A1 (en) 2018-05-17 2020-11-19 Massachusetts Institute Of Technology Systems for electrical stimulation
WO2020106704A2 (en) 2018-11-19 2020-05-28 Progenity, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
WO2020160399A1 (en) 2019-02-01 2020-08-06 Massachusetts Institute Of Technology Systems and methods for liquid injection
US11541216B2 (en) 2019-11-21 2023-01-03 Massachusetts Institute Of Technology Methods for manufacturing tissue interfacing components
CN121197633A (zh) 2019-12-13 2025-12-26 比特比德科有限责任公司 用于将治疗剂递送至胃肠道的可摄取装置

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4564363A (en) * 1983-07-13 1986-01-14 Smithkline Beckman Corporation Delayed action assembly
US4572403A (en) * 1984-02-01 1986-02-25 Rafael Benaroya Timed dispensing device for tablets, capsules, and the like
US4814180A (en) * 1984-03-21 1989-03-21 Alza Corporation Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container
US5071040A (en) * 1990-03-09 1991-12-10 Pfizer Hospital Products Group, Inc. Surgical adhesives mixing and dispensing implement
US5170801A (en) * 1990-10-02 1992-12-15 Glaxo Inc. Medical capsule device actuated by radio-frequency (rf) signal
US5279607A (en) * 1991-05-30 1994-01-18 The State University Of New York Telemetry capsule and process
US5318557A (en) * 1992-07-13 1994-06-07 Elan Medical Technologies Limited Medication administering device
US5423779A (en) * 1993-11-02 1995-06-13 Yeh; Charles R. High efficiency filtration particulate and smoke evacuator system
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
US5853386A (en) * 1996-07-25 1998-12-29 Alaris Medical Systems, Inc. Infusion device with disposable elements
GB9718903D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
EP1018949B1 (en) * 1997-10-02 2005-08-24 Boston Scientific Limited Device for delivering fiber material into a body
DE19849700C2 (de) * 1998-10-28 2001-06-28 Festo Ag & Co Mikroventilanordnung
US6300417B1 (en) * 1998-12-22 2001-10-09 The Texas A&M University System Method for improving the impact resistance and scratch resistance of polymeric systems
FI108813B (fi) * 1999-03-08 2002-03-28 Sonera Smarttrust Oy Menetelmä ja järjestelmä tietoliikennejärjestelmässä
EP1189637B1 (en) * 1999-05-17 2006-08-23 Cancer Research Ventures Limited Compositions for improving bioavailability of orally administered drugs
GB9930000D0 (en) * 1999-12-21 2000-02-09 Phaeton Research Ltd An ingestible device
US6699214B2 (en) * 2000-01-19 2004-03-02 Scimed Life Systems, Inc. Shear-sensitive injectable delivery system
IL150657A0 (en) * 2000-01-20 2003-02-12 Delsys Pharmaceutical Corp Multi-step drug dosage forms
JP2004503207A (ja) * 2000-02-25 2004-02-05 ストラタジーン 核酸をライゲーションする方法および分子クローニング
US8036731B2 (en) * 2001-01-22 2011-10-11 Spectrum Dynamics Llc Ingestible pill for diagnosing a gastrointestinal tract
US6929636B1 (en) * 2000-11-08 2005-08-16 Hewlett-Packard Development Company, L.P. Internal drug dispenser capsule medical device
US6632175B1 (en) * 2000-11-08 2003-10-14 Hewlett-Packard Development Company, L.P. Swallowable data recorder capsule medical device
US6734289B2 (en) * 2001-03-29 2004-05-11 The University Of Chicago Gastrokines and derived peptides including inhibitors
US7022475B2 (en) * 2001-03-29 2006-04-04 St. Jude Children's Research Hospital Genotyping assay to predict CYP3A5 phenotype
JP4744026B2 (ja) * 2001-07-30 2011-08-10 オリンパス株式会社 カプセル内視鏡およびカプセル内視鏡システム
JP2003325439A (ja) * 2002-05-15 2003-11-18 Olympus Optical Co Ltd カプセル型医療装置
US6776165B2 (en) * 2002-09-12 2004-08-17 The Regents Of The University Of California Magnetic navigation system for diagnosis, biopsy and drug delivery vehicles
WO2004054430A2 (en) * 2002-12-16 2004-07-01 Given Imaging Ltd. Device, system and method for selective activation of in vivo sensors
RU2334506C2 (ru) * 2003-01-29 2008-09-27 И-Пилл Фарма Лтд. Активная доставка лекарственного средства в желудочно-кишечном тракте
US20050058701A1 (en) * 2003-01-29 2005-03-17 Yossi Gross Active drug delivery in the gastrointestinal tract
US20040267240A1 (en) * 2003-01-29 2004-12-30 Yossi Gross Active drug delivery in the gastrointestinal tract
US7014640B2 (en) * 2003-03-28 2006-03-21 Depuy Products, Inc. Bone graft delivery device and method of use
US7253166B2 (en) * 2003-04-22 2007-08-07 Irm Llc 6-phenyl-7H-pyrrolo[2,3-d]pyrimidine compounds that induce neuronal differentiation in embryonic stem cells
JP2004350963A (ja) * 2003-05-29 2004-12-16 Olympus Corp カプセル型医療装置
WO2005024687A1 (ja) * 2003-09-02 2005-03-17 Fujitsu Limited 薬服用状況管理方法、薬剤及び薬服用状況管理装置
DE10345837A1 (de) * 2003-10-02 2005-04-21 Bayer Technology Services Gmbh Verfahren zur Bestimmung einer Wirkstoffdosierung
US7393924B2 (en) * 2004-01-06 2008-07-01 Franco Vitaliano Smart bio-nanoparticle elements
US7654985B2 (en) * 2004-03-30 2010-02-02 Given Imaging Ltd. Controlled detachment of intra-luminal medical device
US20060021932A1 (en) * 2004-07-26 2006-02-02 Darnell Justin R Integrated flat panel filter and housing
US7134909B2 (en) * 2004-07-28 2006-11-14 Fujitsu Limited Connector circuit board
US8518022B2 (en) * 2004-08-27 2013-08-27 Medimetrics Personalized Drug Delivery, Inc. Electronically and remotely controlled pill and system for delivering at least one medicament
US7098721B2 (en) * 2004-09-01 2006-08-29 International Business Machines Corporation Low voltage programmable eFuse with differential sensing scheme
SE0402169L (sv) * 2004-09-10 2005-07-26 Car O Liner Ab Kombinerad ramp- och pallbockskonstruktion
WO2006052006A1 (en) * 2004-11-10 2006-05-18 Olympus Corporation Body-insertable apparatus
JP2008521794A (ja) * 2004-11-29 2008-06-26 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 少なくとも一の薬剤を輸送するための、少なくとも一のセンサを有する電子制御式の錠剤およびシステム
CN101107043A (zh) * 2005-01-18 2008-01-16 皇家飞利浦电子股份有限公司 用于释放辐射的电控胶囊
WO2006086479A2 (en) * 2005-02-09 2006-08-17 Children's Medical Center Corporation Device for mixing and delivering fluids for tissue repair
US8021357B2 (en) * 2005-05-27 2011-09-20 Olympus Corporation Body-insertable apparatus
AU2006261893A1 (en) * 2005-06-23 2007-01-04 Combinatorx, Incorporated Improved dosage forms for movement disorder treatment
US8728289B2 (en) * 2005-12-15 2014-05-20 Medtronic, Inc. Monolithic electrodes and pH transducers
US8062287B2 (en) * 2005-12-22 2011-11-22 Koninklijke Philips Electronics N V Device for controlled release of chemical molecules
RU2009101475A (ru) * 2006-06-20 2010-07-27 Конинклейке Филипс Электроникс, Н.В. (Nl) Электронная капсула и способ для лечения желудочно-кишечного заболевания
US20080099356A1 (en) * 2006-10-31 2008-05-01 Calyx & Corolla, Inc. Flower shipment packaging
WO2008099356A2 (en) * 2007-02-15 2008-08-21 Koninklijke Philips Electronics N.V. Drug delivery device

Similar Documents

Publication Publication Date Title
JP2017221711A5 (enExample)
JP6230772B2 (ja) 患者に対する薬物の投与
CN112585690B (zh) 用于制作含有药物活性物质的个性化个体单位剂量的系统和方法
Korte et al. 3D-printed network structures as controlled-release drug delivery systems: dose adjustment, API release analysis and prediction
Cantor et al. Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride
JP2017501381A5 (enExample)
Chakka et al. 3D printing of pharmaceuticals for disease treatment
US12383495B2 (en) Resident articles for gram-level dosing
JP2010530868A (ja) デュロキセチン製剤
JP2020516663A5 (enExample)
Carrasco et al. Aspergillosis: update on causes, diagnosis and treatment
JP2014129405A5 (enExample)
Kern Sliwa et al. An assessment of injection site reaction and injection site pain of 1‐month and 3‐month long‐acting injectable formulations of paliperidone palmitate
JP2009514794A5 (enExample)
Brayden et al. Stomaching drug delivery
Muchmore et al. Inhaled insulin delivery–where are we now?
Harb et al. Aerosol drug‐delivery and short‐term clinical outcomes of suboptimal peak inspiratory flow rate in chronic obstructive pulmonary disease
Everson et al. Somatostatin, estrogen, and polycystic liver disease
Lipworth β-Adrenoceptor genotype and bronchoprotective subsensitivity with long-acting β-agonists in asthma
Badwan et al. Enhancement of oral bioavailability of insulin in humans
JP2016525530A5 (enExample)
Avanu et al. Nano-steps in altered opioid pharmacokinetics: a perspective on potential drug delivery post-bariatric surgery applications
Cottone et al. Infliximab and ulcerative colitis
Singh Relevance of distinctions and parallels between the US and EU guidelines for determination of comparative effectiveness and safety of the orally inhaled drug products
JP2024518009A (ja) 患者に最適化した投与剤形の製造方法